GettyImages-1790844523 (1)

Changing Landscape of Treatment Options for ALL with CD19, CD22 Monoclonal Antibodies and AML with IDH1/2, FLT3, CD33 and Hedgehog Pathway Targeted Agents – Enduring Webcast

Read more
CancerNet

Evolving Landscape of Treatment for Hepatocellular Carcinoma with Multi-Targeted Tyrosine Kinase Inhibitors and Immunotherapy – Enduring Webcast

Read more
GettyImages-1790845584 (1)

Changing Landscape of Therapies for Urothelial Carcinoma and Non-Muscle-Invasive Bladder Cancer with PD-1/PD-L1 Inhibitors, ADC and Recombinant Adenovirus Mediated Interferon-a2b – Enduring Webcast

Read more
CancerNet

Changing Landscape of Targeted and Immunotherapies for Genitourinary Cancers – Enduring Webcast

Read more
CancerNet

Changing Treatment Landscape of Metastatic Head and Neck Squamous Cell Carcinoma with Anti-PD-1/PD-L1 Agents – Enduring Webcast

Read more
CancerNet

New Paradigms in the Treatment of Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia and Chronic Myeloid Leukemia – Module – 2 – Enduring Webcast

Read more
CancerNet

New Paradigms in the Treatment of Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia and Chronic Myeloid Leukemia – Module – 1 – Enduring Webcast

Read more
GettyImages-2222698522 (1)

New Paradigms in the Treatment of Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia and Chronic Myeloid Leukemia

Read more
GettyImages-953188648 (1)

Update on Treatment Options for Acute Lymphoblastic Leukemia with An Emphasis on CD19, CD22 Monoclonal Antibodies and Anti-CD19 CAR T-cell Therapy – Enduring Webcast

Read more
GettyImages-2173675916 (1)

Changing Landscape of Treatment Strategies of TKI Interruptions, Discontinuations and Switching in Patients with Chronic Myeloid Leukemia – Enduring Webcast

Read more